Source: GlobeNewswire

Press Release: Cidara : Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial results for the three months ended June 30, 2019 and provided an update on its corporate activities and product pipeline.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Jeffrey Stein's photo - President & CEO of Cidara

President & CEO

Jeffrey Stein

CEO Approval Rating


Cidara develops and commercializes novel anti-infectives and immunotherapies for the treatment of fungal infections. Read more